Gibson, Dunn & Crutcher

HWN Energy Ltd. Announces Closing of Two Acquisitions, Greatly Expanding Overall Canadian Footprint

Retrieved on: 
Monday, February 6, 2023

CALGARY, Alberta, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Hawthorne Energy, LLC (“Hawthorne”) through its Canadian subsidiary HWN Energy Ltd. (“HWN Energy”) today announced the closing of two large complementary asset acquisitions located in Central and Northern Alberta.

Key Points: 
  • CALGARY, Alberta, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Hawthorne Energy, LLC (“Hawthorne”) through its Canadian subsidiary HWN Energy Ltd. (“HWN Energy”) today announced the closing of two large complementary asset acquisitions located in Central and Northern Alberta.
  • Pro forma for the transactions, HWN Energy will have a substantial, low decline production base of more than 15,000 boe/d (~50% oil/liquids) with significant reserve value and cash flow generation capacity.
  • “We are excited to continue our growth in Alberta,” said John Oberg, HWN Energy’s Chief Executive Officer.
  • Gibson, Dunn & Crutcher LLP and Lawson Lundell LLP acted as legal advisors to HWN Energy with respect to the acquisitions.

Verisk Announces Closing of Wood Mackenzie Sale

Retrieved on: 
Thursday, February 2, 2023

JERSEY CITY, N.J., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Verisk (Nasdaq: VRSK), a leading global data analytics provider, today announced the closing of the sale of Wood Mackenzie to an affiliate of Veritas Capital (“Veritas”), a leading investor at the intersection of technology and government.

Key Points: 
  • JERSEY CITY, N.J., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Verisk (Nasdaq: VRSK), a leading global data analytics provider, today announced the closing of the sale of Wood Mackenzie to an affiliate of Veritas Capital (“Veritas”), a leading investor at the intersection of technology and government.
  • “This marks a significant value-creating step for Verisk, which returns the company to its roots as a dedicated strategic partner to the global insurance industry,” said Lee Shavel, president and CEO, Verisk.
  • The terms of the sale of Wood Mackenzie to Veritas were described in a previous press release, which can be found here .
  • Morgan Stanley & Co LLC is acting as financial advisor and Davis Polk & Wardwell LLP as legal advisor to Verisk in connection with the transaction.

China Index Holdings Enters into Definitive Agreement for Going-Private Transaction

Retrieved on: 
Thursday, December 22, 2022

BEIJING, Dec. 22, 2022 (GLOBE NEWSWIRE) -- China Index Holdings Limited (NASDAQ: CIH), (“CIH” or the “Company”), a leading real estate information and analytics service platform provider in China, today announced that it has entered into an Agreement and Plan of Merger (the “Merger Agreement”) with CIH Holdings Limited (“Parent”) and CIH Merger Sub Holdings Limited (“Merger Sub”), a wholly owned subsidiary of Parent.

Key Points: 
  • BEIJING, Dec. 22, 2022 (GLOBE NEWSWIRE) -- China Index Holdings Limited (NASDAQ: CIH), (“CIH” or the “Company”), a leading real estate information and analytics service platform provider in China, today announced that it has entered into an Agreement and Plan of Merger (the “Merger Agreement”) with CIH Holdings Limited (“Parent”) and CIH Merger Sub Holdings Limited (“Merger Sub”), a wholly owned subsidiary of Parent.
  • Certain shareholders of the Company, including Fang Holdings Limited, ACE Smart Investments Limited, Media Partner Technology Limited, Next Decade Investments Limited, Karistone Limited, Open Land Holdings Limited, True Knight Limited, Digital Link Investments Limited, General Atlantic Singapore Fund Pte.
  • Fang Holdings Limited has also executed and delivered to the Company a limited guarantee in favor of the Company pursuant to which it agreed to guarantee certain payment obligations of Parent under the Merger Agreement.
  • In connection with the Merger, the Company will prepare and mail a Schedule 13E-3 Transaction Statement (the “Schedule 13E-3”) to its shareholders.

GE Completes Separation of GE HealthCare

Retrieved on: 
Wednesday, January 4, 2023

GE (NYSE: GE) announced that it has completed the separation of its healthcare business, launching GE HealthCare Technologies Inc. (“GE HealthCare”), a global leader in Precision Care.

Key Points: 
  • GE (NYSE: GE) announced that it has completed the separation of its healthcare business, launching GE HealthCare Technologies Inc. (“GE HealthCare”), a global leader in Precision Care.
  • H. Lawrence Culp Jr., Chairman and CEO, GE and CEO, GE Aerospace, said, “The successful spin-off of GE HealthCare marks a pivotal moment in our transformation into three independent companies focused on critical, growing sectors.
  • With lean and innovation at our core, we could not be more excited about the future.”
    Holders of GE common stock received one share of GE HealthCare common stock for every three shares of GE common stock held.
  • GE is retaining approximately 19.9 percent of the shares of GE HealthCare common stock.

SKLAR KIRSH ELEVATES CORPORATE ATTORNEY JENNIFER COHEN TO PARTNER

Retrieved on: 
Thursday, January 5, 2023

LOS ANGELES, Jan. 5, 2023 /PRNewswire/ -- Los Angeles-based law boutique Sklar Kirsh LLP announced today that it has elevated corporate attorney Jennifer Cohen to Partner, effective January 1, 2023.

Key Points: 
  • LOS ANGELES, Jan. 5, 2023 /PRNewswire/ -- Los Angeles-based law boutique Sklar Kirsh LLP announced today that it has elevated corporate attorney Jennifer Cohen to Partner, effective January 1, 2023.
  • "Jenny exemplifies what it means to be a Partner," said Sklar Kirsh Co-Chairman Jeffrey A. Sklar .
  • Cohen represents corporate clients, founders, business owners, private equity firms and their portfolio companies in a wide range of corporate matters including mergers and acquisitions, joint ventures, equity investments, commercial transactions and corporate governance.
  • Prior to joining the firm, Cohen was corporate counsel to two sports and entertainment firms, Elevate Sports Ventures and VenueNext.

Mobile Infrastructure Corporation To Be Publicly Listed In Merger With Fifth Wall Acquisition Corp. III

Retrieved on: 
Tuesday, December 13, 2022

Brad Greiwe , Co-Founder and Managing Partner at Fifth Wall, shared, Fifth Wall has long evaluated the landscape of parking owner-operators and the technologies applicable to those businesses.

Key Points: 
  • Brad Greiwe , Co-Founder and Managing Partner at Fifth Wall, shared, Fifth Wall has long evaluated the landscape of parking owner-operators and the technologies applicable to those businesses.
  • This document relates to the proposed merger involving Fifth Wall Acquisition Corp. III ("FWAC") and Mobile Infrastructure Corp. ("MIC").
  • FWAC is sponsored by Fifth Wall Acquisition Sponsor III LLC (the "FWAC Sponsor"), which is an affiliate of Fifth Wall.
  • However, FWAC is an independent publicly-traded company, and not a member of Fifth Wall or the Fifth Wall Group.

Veritas Capital Completes Acquisition of Sequa from Carlyle

Retrieved on: 
Tuesday, December 13, 2022

Veritas Capital (Veritas), a leading technology and government investment firm, today announced that an affiliate of Veritas has completed the acquisition of Sequa Corporation (Sequa), parent company of Chromalloy, from funds managed by global investment firm Carlyle (NASDAQ: CG).

Key Points: 
  • Veritas Capital (Veritas), a leading technology and government investment firm, today announced that an affiliate of Veritas has completed the acquisition of Sequa Corporation (Sequa), parent company of Chromalloy, from funds managed by global investment firm Carlyle (NASDAQ: CG).
  • Sequa, through its subsidiary Chromalloy, is a global technology company and a leading solutions provider for aircraft engines and gas turbines.
  • Chromalloy possesses distinctive engine and turbine component design and development expertise as well as advanced engineering capabilities that support proprietary component solutions.
  • Veritas seeks to create value by strategically transforming the companies in which it invests through organic and inorganic means.

CenterOak Partners LLC Completes Sale of Wetzel’s Pretzels

Retrieved on: 
Thursday, December 8, 2022

CenterOak Partners LLC (CenterOak), a Dallas-based private equity firm, today announced the completion of the sale of Wetzels Pretzels (Wetzels or the Company), to MTY Franchising USA, Inc., a wholly owned subsidiary of MTY Food Group Inc. (TSX:MTY) for a cash purchase price of $207 million.

Key Points: 
  • CenterOak Partners LLC (CenterOak), a Dallas-based private equity firm, today announced the completion of the sale of Wetzels Pretzels (Wetzels or the Company), to MTY Franchising USA, Inc., a wholly owned subsidiary of MTY Food Group Inc. (TSX:MTY) for a cash purchase price of $207 million.
  • We are pleased to see the successful culmination of our investment in Wetzels, said Randall Fojtasek, CEO and Co-Managing Partner of CenterOak.
  • Founded in 1994, Wetzels Pretzels is the second largest U.S. franchisor and owner of quick service restaurants operating in the soft pretzel category.
  • CenterOak Partners LLC is a private equity firm with a focus on making control-oriented investments in middle market companies organized or operating in the United States.

KKR to acquire Clinisupplies to accelerate growth and help build a leading international chronic care medical devices platform

Retrieved on: 
Tuesday, December 6, 2022

KKR, a leading global investment firm, announced today that KKR has agreed to acquire Clinisupplies, a market leader in continence care products in the UK, from Healthium.

Key Points: 
  • KKR, a leading global investment firm, announced today that KKR has agreed to acquire Clinisupplies, a market leader in continence care products in the UK, from Healthium.
  • Clinisupplies is a UK-based manufacturer and distributor of continence care products, including urinary collecting devices and catheters.
  • KKR is investing in Clinisupplies through KKR Health Care Strategic Growth Fund II, a $4.0 billion fund focused on investing in high-growth health care companies.
  • Clinisupplies is a leading UK-based manufacturer and supplier of medical appliances specialising in continence products for managing acute and chronic conditions.

Apogee Therapeutics Launches with $169 Million to Develop Potentially Best-in-Class Therapies for Immunological and Inflammatory Disorders

Retrieved on: 
Wednesday, December 7, 2022

SAN FRANCISCO, Dec. 7, 2022 /PRNewswire/ -- Apogee Therapeutics, LLC, a biotechnology company advancing novel, potentially best-in-class therapies to address the needs of the millions of people living with immunological and inflammatory disorders, today announced the closing of a $149 million Series B financing. Proceeds from the financing will be used to support Apogee's plans to advance its lead pipeline program into the clinic in 2023 and expand the leadership, scientific, and clinical teams led by Chief Executive Officer Michael Henderson, M.D.

Key Points: 
  • Founding investors, Fairmount and Venrock Healthcare Capital Partners, also participated in the oversubscribed Series B financing.
  • "Apogee is advancing a pipeline of potential best-in-class therapies targeting clinically validated biological pathways with the potential to drastically impact the lives of millions living with immunological and inflammatory disorders," said Dr. Henderson.
  • Apogee Therapeutics, LLC is a biotechnology company advancing novel, potentially best-in-class therapies to address the needs of the millions of people living with immunological and inflammatory disorders.
  • The company rapidly advances therapies through a range of opportunities, from new company creation and strategic partnerships to shaping programs in-house.